title: Systematic method of development in liquid chromatography applied to the determination of antiepileptic drugs.
abstract: The object of a liquid-chromatographic analysis is to separate, identify, and quantitate the constituents of interest in a sample mixture within an acceptable analysis time. This will be achieved by a systematic analysis development rather than by a trial-and-error approach. Such a systematic procedure requires a knowledge of the chromatographic parameters governing resolution and analysis time and their relative influences on resolution and its experimental implication. Furthermore, basic information about the mechanisms of the modes of liquid chromatography (adsorption, partition, ion exchange, and steric exclusion) and about the types of sample which can be preferentially analyzed by them is necessary. This information leads to a rational selection of the separation system that promises the best chance of success. In the subsequent experimental work, the analyst systematically measures and calculates resolution and analysis time as functions of selectivity, capacity, and efficiency of the phase system under selected chromatographic conditions. The essential chromatograms, tables, and graphs resulting from this systematic method of development are documented so that it is possible to replicate the analysis procedure in the laboratories involved. The result is a set of chromatographic conditions capable of achieving an optimum compromise between resolution and analysis time. The procedure is applied to routine therapeutic drug monitoring of antiepileptic drugs in patient serum.
mesh_terms: D000927:Anticonvulsants / Q000032:analysis*; D002220:Carbamazepine / Q000032:analysis; D002853:Chromatography, Liquid / Q000379:methods*; D005013:Ethosuximide / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010634:Phenobarbital / Q000032:analysis; D010672:Phenytoin / Q000032:analysis; D012995:Solubility; D013696:Temperature
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine; D005013:Ethosuximide; D010672:Phenytoin; D010634:Phenobarbital